Clinical Trial Update: Assessment of Prospective CYP2C19 Genotype Guided Dosing of Anti-Platelet Therapy in Percutaneous Coronary Intervention [NA]

View source ↗

Summary

Completed clinical trial assessing genotype-guided dosing of antiplatelet therapy in patients undergoing percutaneous coronary intervention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Syndrome

Snippet

Sponsor: University of Pennsylvania | Conditions: Acute Coronary Syndrome, Cardiovascular Diseases | NA | Status: COMPLETED | Results posted: 2018-11-07